Hazardous Drug Export Prevention Act
This bill died when its Congress ended.
Bills don't carry over between Congresses. Without re-introduction in a new session, it cannot advance.
Hazardous Drug Export Prevention Act - Amends the Federal Food, Drug, and Cosmetic Act to permit the export of certain unapproved drugs if specified conditions are met. Includes among such conditions that such drug: (1) has been shown safe and effective; (2) has been approved by the importing country; (3) has not been disapproved by any country on a list of countries with highly developed regulatory procedures and testing requirements for drugs; and (4) is clearly labeled for export to a named country on the shipping label. Sets forth application procedures for exporting such drugs. Lists countries with a highly developed drug regulatory program which may receive such drugs. Provides for additions and deletions to such list. Requires an approved exporter to report any changes in the importing country's regulation of the drug in question to the Secretary of Health and Human Services, requiring termination of such exporting permission should the drug be disapproved. Prohibits a change in labeling for approved new or animal drugs exported if such change affects the safety or efficacy of the drugs. Permits civil actions as specified to restrain such misbranding and to restrain the export of drugs to an unauthorized country.
Filed in the House
This house bill has been filed and is working its way through Congress. It will need to pass both the House and the Senate, then be signed by the President to become law.
Who introduced this
Ask AI About This Bill
Get plain-language answers with direct quotes from the bill text.
Your Representatives
Enter your address to see how your representatives voted on this bill.
Your address is only used to find your district and is never saved. See how it works
Votes
Public Opinion
No votes yet — be the first to weigh in.
to cast your vote
Your voice matters — let representatives know where you stand.
Comments
No comments yet. to be the first to weigh in.